[Program, AIDS Clinical Trials Group Meeting (20th: 1995: Washington, DC)]

DECEMBER 1995 ACTG MEETING POSTER SESSION EXHIBIT

Sunday (December 3), 2:00 P.M. - Tuesday (December 5), 2:00 P.M.
POSTER TITLES

ABSTRACT TITLE/AUTHORS

#1

CAN HIV INFECTED ADOLESCENTS BE SUCCESSFULLY ENROLLED IN CLINICAL
TRIALS? THE ACTG PROTOCOL 220 EXPERIENCE
-- D'Angelo, Lindsey, Zimmer, Futterman, Abdelian and ACTG 220 Team

#2

CASE STUDY:
-- Hutcheon,

CMV RETINITIS IN AN HIV INFECTED CHILD
McSherry, Mickey, Kazista and Daniels

#3

#4

#5

QUALITY OF LIFE IN CHILDREN 6 MONTHS TO 4 YEARS OF AGE ENROLLED IN
ACTG 219
-- Clark, Gortmaker, Lenderking and Oleske
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL STATUS IN CHILDREN
WITH HIV DISEASE: TYPE AND STABILITY OF CAREGIVING
-- Chase, Pelton, McIntosh and Kammerer
"ONE STOP SHOPPING:" THE ADVANTAGES OF COORDINATING RESEARCH
PROTOCOLS INTO THE PRIMARY CARE SETTING
-- Kohrs and Dayton
SYSTEMS OF ORGANIZATION AIMED AT MAXIMIZING DATA
-- Alfonso, Doyle, Agosto, Akinmulero, Strong, Herrin and O'Sullivan
A RANDOMIZED TRIAL TO EVALUATE THE EFFECTIVENESS OF ELECTIVE
CESAREAN SECTION IN DECREASING MOTHER-TO-CHILD HIV-1 TRANSMISSION
-- Mandelbrot, Newell, Pardi, Parazzini, Bazin, and the
International "MOD Trial" Group
ATYPICAL HIV-1 CULTURE RESULT LEADS TO IDENTIFICATION OF HIV-2
POSITIVE PATIENT
-- Kabat, Schable, Liu, Zhang and Yogev

#6

#7

#8

#9

AN EFFORT TO STANDARDIZE MEDICATION
INFORMATION FOR SPECIFIC ACTG PROTOCOLS
-- Daniel, Forcht, Kirk, Royal and Shaver

AND STUDY PARTICIPANT

1 of 2